Nicholas Brittain - Chief Operating Officer, Akesa

Nicholas Brittain

Chief Operating Officer

MBA, B. Communications (Public Relations)

Connect on LinkedIn

His strategic acumen and operational expertise have positioned him for success as Akesa’s Chief Operating Officer. In this role, Nicholas is responsible for driving operational excellence and ensuring Akesa’s business functions are aligned with its strategic objectives. Leveraging his extensive background in marketing and communications, Nicholas continues to enhance Akesa’s brand presence while overseeing critical operations that support sustainable growth.

Throughout his career, Nicholas has demonstrated a talent for managing strategic relationships, leading cross-functional teams, and implementing transformative change management initiatives. His ability to foster partnerships and streamline operations has enabled him to deliver exceptional results in complex, fast-paced environments.

Before transitioning to the COO role, Nicholas led marketing and communications efforts, spearheading brand transformations and go-to-market strategies that significantly improved customer acquisition and engagement. His entrepreneurial mindset, honed through founding a proptech startup and consulting on digital strategy, further showcases his adaptability and innovative approach to problem-solving.

An MBA graduate from Melbourne Business School, Nicholas brings a unique blend of strategic insight and hands-on execution to his leadership at Akesa, ensuring operational excellence and continued growth.

  • New digital platform unlocks access to private prescription medicines

    Akesa launches digital platform to unlock access to private prescription medicines in Australia

  • Akesa targets emissions cuts, reduces supply waste

    Going beyond sustainability to drive alternative pathways to medicine access

  • Akesa and Rock8 partnership to unlock access to pharmaceutical product for APAC clinical trials

    Akesa partners with Rock8 Science to boost pharmaceutical access for APAC clinical trials, improving supply chain transparency and trial readiness across the region.

  • Akesa secures pharmaceutical supply chain executive

    Akesa appoints supply chain and compliance leader Priscilla Thiyageas to drive the company’s APAC expansion.

    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.